Scientists test COVID drug safety in people with kidney issues
NCT ID NCT06698549
Summary
This early study tested an oral COVID-19 drug called ALG-097558. It aimed to see how the drug is processed in the body of people with severe kidney problems compared to healthy people. The main goal was to check if the drug is safe and how kidney function changes the amount of drug in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Genesis Clinical Trials
Tampa, Florida, 33603, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.